Lantheus Holdings, Inc. (LNTH) Fair Value 2026

LNTH · In Vitro & In Vivo Diagnostic Substances ·

By CirclFi Research Team · Data from SEC EDGAR, FRED & GDELT

Quality Score

10.0 /10

32 fundamental signals · 13 models active

Value Trap Risk

SAFE (12/100)

Quick Summary — As of 2026-07-13, Lantheus Holdings, Inc. (LNTH) trades at $105.39, approximately 34% below CirclFi’s Bayesian DCF fair value of $159.66. QOC: 10.0/10. Value Trap Risk: 12/100 (SAFE). 13/13 models active.

Key Facts

Ticker
LNTH
Price
$105.39
Quality Score
10.0/10
Value Trap Risk
12/100
Models Active
13/13
Last Updated
Strength: Bayesian DCF suggests +51.5% upside with 64% confidence
Risk: Limited model coverage (13/13) may reduce confidence

Valuation Matrix

13 Intrinsic Value Models vs. Current Price ($105.39)

Core Models (Unlocked)
Model Fair Value Upside
Bayesian DCF
High Conviction
$159.66 +51.5%
Earnings Power Value
High Conviction
$49.18 -53.3%
CUCE Ensemble
Low Conviction
$118.57 +12.5%
First Chicago
High Conviction
$151.29 +43.6%

Unlock the Full Matrix

Access 9 additional models including EROIC Spread, Markov DDM, and more.

$1.30 / day

Billed monthly ($39/mo) or annually ($299/yr)

Unlock All 13 Models →

Cancel anytime · No contracts · Instant access

What Is Lantheus Holdings, Inc. (LNTH) Worth in 2026?

According to the CirclFi Deep Alpha Valuation Engine, Lantheus Holdings, Inc.'s intrinsic value is estimated at $105.40, presenting a divided outlook at the current price of $105.39. With an average implied return of +0.0% across a split 5–7 (bull–bear) consensus, the model spread of +212.8% underscores analytical uncertainty. Notably, RCMH-DCF sees the most upside at +119.0% (fair value: $230.75), while Dynamic NAV is the most conservative at -93.9% ($6.44). The spread between these extremes — +212.8% — reveals how different analytical frameworks can reach starkly different conclusions. Among models with highest confidence, EPV lean bearish — adding weight to the bearish side of the thesis.

What Do the Models Say About LNTH?

13 of 13 models are currently active for LNTH. Of these, 5 models suggest upside while 8 models suggest overvaluation. The Bayesian DCF estimates LNTH's intrinsic value at $159.66, implying +51.5% upside from the current price. See which stocks rank higher →

How Does LNTH Rank in In Vitro & In Vivo Diagnostic Substances?

Among 17 In Vitro & In Vivo Diagnostic Substances stocks, LNTH ranks #2 by Quality of Company score. CirclFi's QOC score of 10.0/10 evaluates 32 fundamental signals. A score of 10.0 places LNTH in the top tier.

Lantheus Holdings, Inc. operates in a competitive landscape where fundamental quality metrics are key differentiators for long-term value creation.

Is LNTH a Value Trap?

CirclFi's Value Trap algorithm assigns LNTH a score of 12/100 (SAFE). This indicates minimal risk. Fundamentals are healthy. The score cross-references apparent undervaluation against fundamental deterioration signals. Browse lowest value-trap stocks →

Multi-Model Methodology

13 of 13 models are active for Lantheus Holdings, Inc.. Broad coverage provides high confidence. Each model applies a fundamentally different valuation philosophy. See the complete methodology →

According to the CirclFi Deep Alpha Valuation Engine, Lantheus Holdings, Inc. scores 10.0 out of 10 on our 32-signal quality assessment, a elite rating that ranks among the highest-quality businesses in our coverage universe. The QOC score synthesizes profitability margins, revenue growth reliability, debt management, and capital allocation into a single metric designed to separate durable businesses from statistically cheap ones.

The gap between the most bullish and bearish model spans +212.8% — demonstrating why single-model analysis is dangerous. Browse all stocks with 13-model coverage →

Data Sources & Confidence

Every LNTH valuation is built from SEC EDGAR XBRL filings — 700+ standardized financial tags. Macroeconomic context from FRED calibrates discount rates, while GDELT news sentiment feeds into our Sentiment SOTP model. All pipelines run daily. Read the complete data methodology →

Across LNTH's 13 active models, average confidence is 46%. Lower confidence may reflect limited history or high volatility.

CirclFi's output is a research starting point, not a buy/sell signal. All data updates daily. Read the full methodology →

This analysis is produced by the CirclFi Valuation Engine using quantitative models applied to SEC EDGAR filings, public market feeds, and FRED macroeconomic indicators. It is not financial advice.

Read the full investment analysis: Should You Buy Lantheus Holdings, Inc. Stock in 2026? →

Bull case, bear case, risk factors & peer comparison — updated daily

Which Similar In Vitro & In Vivo Diagnostic Substances Stocks Should You Also Analyze?

8 related In Vitro & In Vivo Diagnostic Substances stocks with 13-model coverage

Read investment analysis: IDXX · NEOG · ICCC · QDEL · NTLA

Frequently Asked Questions About Lantheus Holdings, Inc.

What is Lantheus Holdings, Inc.'s intrinsic value in 2026?

Based on CirclFi's 13-model analysis, Lantheus Holdings, Inc. (LNTH) has multiple fair value estimates. The Bayesian DCF model runs 10,000 Monte Carlo simulations with jump-diffusion to estimate intrinsic value at $159.66. The Quality of Company score is 10.0/10 across 32 fundamental signals. All models use SEC EDGAR filings updated daily. See our methodology page for how each model works.

Is LNTH overvalued or undervalued right now?

At $105.39, 5 of 13 active models suggest LNTH may be undervalued, while 8 indicate potential overvaluation. The assessment depends on which methodology best fits Lantheus Holdings, Inc.'s business model in In Vitro & In Vivo Diagnostic Substances.

What does a Quality of Company score of 10.0 mean for LNTH?

Lantheus Holdings, Inc.'s QOC of 10.0/10 reflects 32 fundamental signals: profitability margins, revenue growth consistency, balance sheet leverage, free cash flow generation, and capital allocation efficiency. Scores above 7 indicate strong fundamentals and disciplined management.

How many valuation models does CirclFi run on LNTH?

CirclFi analyzes LNTH with 13 institutional-grade models daily: Bayesian DCF (Monte Carlo + jump-diffusion), EPV (Greenwald zero-growth), EROIC Spread (McKinsey reinvestment), First Chicago (3-scenario), Markov DDM (regime-switching), ML-RIV (machine learning residual income), Dynamic NAV (asset-based), PWERM (option-theoretic), Regime Cross-Sectional (relative), Sentiment SOTP (hybrid), CUCE Ensemble (meta-model), FTNN Topology (neural network), and RCMH-DCF (conditional regime). Currently 13 of 13 are active for this stock. Read the full methodology →

Is LNTH a value trap in 2026?

Lantheus Holdings, Inc.'s Value Trap score is 12/100 (SAFE). This low score indicates the current valuation is not artificially depressed by fundamental deterioration, suggesting genuine opportunity rather than a trap. Browse stocks by value-trap risk →

You’ve done the research. Don’t stop at half the picture.

Stop collecting opinions. Let 13 mathematical frameworks give you clarity on LNTH.

Unlock All 13 Fair Values — $39/mo

Cancel anytime · Less than a cup of coffee · Instant access